ADVFN US – Market Content Editor

  • Dollar strengthens ahead of key CPI report; euro eases as markets eye geopolitics

    Dollar strengthens ahead of key CPI report; euro eases as markets eye geopolitics

    The U.S. dollar firmed slightly on Thursday as traders positioned themselves ahead of a closely watched inflation release, while escalating U.S.-China trade tensions and fresh sanctions on Russia added to safe-haven demand. At 03:50 ET (07:50 GMT), the U.S. Dollar Index rose 0.1% to 98.805, recovering some ground after notable losses the previous week. Safe-haven…

  • The tungsten reckoning: What investors deserve to know

    The tungsten reckoning: What investors deserve to know

    Lyndsay Malchuk sits down with Matthias Greiffenberger, senior analyst at GBC AG, to discuss Almonty Industries’ (NASDAQ:ALM, TSX:AII) bold attempt to challenge China’s dominance in the tungsten market. This in-depth conversation covers the geopolitics of critical minerals, the operational and financial realities of Almonty’s Sangdong project, and what the future holds for Western tungsten supply. Whether…

  • U.S. Stocks Close Mostly Lower As Netflix Slumps On Disappointing Earnings

    U.S. Stocks Close Mostly Lower As Netflix Slumps On Disappointing Earnings

    Following the lackluster performance seen during Tuesday’s session, stocks moved mostly lower during trading on Wednesday. The major averages all moved to the downside on the day, with the Dow pulling back off yesterday’s record closing high. The major averages climbed well off their worst levels in late-day trading but remained firmly negative. The Nasdaq…

  • iPower Stock Jumps as Company Pursues Non-Bank Financing Alternatives

    iPower Stock Jumps as Company Pursues Non-Bank Financing Alternatives

    iPower Inc. (NASDAQ:IPW) surged 11.3% on Wednesday after the company revealed plans to pursue alternative funding arrangements to replace its existing bank-backed asset-based lending facility. The e-commerce retailer said it is evaluating non-bank financing options designed to provide “greater flexibility and alignment” with its operating profile and long-term growth strategy. The company believes this shift…

  • Intuitive Surgical Shares Soar After Big Q3 Earnings Beat

    Intuitive Surgical Shares Soar After Big Q3 Earnings Beat

    Intuitive Surgical Inc (NASDAQ:ISRG) surged more than 17% after the opening bell on Wednesday following a blockbuster third-quarter earnings report that blew past Wall Street expectations. The strong results were fueled by surging procedure volumes and growing adoption of its next-generation da Vinci 5 surgical system. The company posted adjusted earnings of $2.40 per share,…

  • Owlet Shares Drop After Announcing $30 Million Public Offering

    Owlet Shares Drop After Announcing $30 Million Public Offering

    Owlet Inc (NYSE:OWLT) saw its stock fall 7.2% on Wednesday after the company announced the pricing of a public offering valued at approximately $30 million. The offering includes 4,196,000 shares of Class A common stock priced at $7.15 per share. The company also granted underwriters a 30-day option to purchase up to an additional 629,400…

  • NVR Tops Q3 Estimates Despite Slowing Housing Market

    NVR Tops Q3 Estimates Despite Slowing Housing Market

    NVR, Inc. (NYSE:NVR) reported third-quarter earnings on Wednesday that came in ahead of analyst forecasts, even as the company continues to face headwinds in the housing market. The homebuilder posted earnings of $112.33 per diluted share, topping the analyst consensus of $109.36. Revenue reached $2.56 billion, slightly above the $2.55 billion estimate. However, the results…

  • Nurix Therapeutics Shares Surge After Launch of Pivotal Phase 2 Trial

    Nurix Therapeutics Shares Surge After Launch of Pivotal Phase 2 Trial

    Nurix Therapeutics Inc (NASDAQ:NRIX) saw its stock jump 10% on Wednesday after announcing the start of its pivotal DAYBreak clinical trial — a single-arm Phase 2 study evaluating bexobrutideg in patients with relapsed or refractory chronic lymphocytic leukemia (CLL). The biopharmaceutical company, which specializes in targeted protein degradation therapies, will test a once-daily 600 mg…

  • Avadel Pharmaceuticals Shares Climb on $2.1 Billion Acquisition by Alkermes

    Avadel Pharmaceuticals Shares Climb on $2.1 Billion Acquisition by Alkermes

    Avadel Pharmaceuticals PLC (NASDAQ:AVDL) rose 4.1% in pre-market trading on Wednesday after announcing it will be acquired by Alkermes plc (NASDAQ:ALKS) in a deal valued at approximately $2.1 billion. Under the agreement, Alkermes will pay $18.50 per share in cash at closing. Shareholders may also receive an additional $1.50 per share through a contingent value…

  • POET Technologies Shares Jump After Securing $5M Production Order

    POET Technologies Shares Jump After Securing $5M Production Order

    POET Technologies Inc. (NASDAQ:POET) saw its stock rise 7% after announcing it had received a production order worth more than $5 million for its POET null optical engines from a leading systems integrator. The order marks a key commercial milestone for POET, reinforcing the market readiness of its optical engine technology, which is designed to…